Search

everythinglearnresearchcommunity

for

Search:↓

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Platelet-rich plasma is beneficial in various plastic surgery applications, but more research is needed to standardize its use.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Low-level laser therapy effectively treats hair loss and promotes hair growth.

Surgeons should evaluate new technologies critically, offer a range of services including non-surgical options, and be aware of marketing influences to meet patient needs and maintain a successful practice.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Best solution for storing hair grafts is saline with ATP at 4 degrees Celsius, but no definitive best method was confirmed.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

The 2024 guideline updates recommendations for genetic testing, imaging, and sperm retrieval in male infertility.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Some medications can help increase sexual desire and function in women.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The meeting concluded with optimism about increasing research and better management of vitiligo.